Ephrin-B2/Fc promotes proliferation and migration, and suppresses apoptosis in human umbilical vein endothelial cells

Li-Chun Zheng; Xiao-Qing Wang; Kun Lu; Xiao-Ling Deng; Cheng-Wei Zhang; Hong Luo; Xu-Dong Xu; Xiao-Man Chen; Lu Yan; Yi-Qing Wang; Song-Lin Shi

doi:10.18632/oncotarget.17298

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Research Papers:

Ephrin-B2/Fc promotes proliferation and migration, and suppresses apoptosis in human umbilical vein endothelial cells

Li-Chun Zheng, Xiao-Qing Wang, Kun Lu, Xiao-Ling Deng, Cheng-Wei Zhang, Hong Luo, Xu-Dong Xu, Xiao-Man Chen, Lu Yan, Yi-Qing Wang _ and Song-Lin Shi

PDF | HTML | Supplementary Files | How to cite

Oncotarget. 2017; 8:41348-41363. https://doi.org/10.18632/oncotarget.17298

Metrics: PDF 1726 views | HTML 2808 views | ?

Abstract

Li-Chun Zheng1,2,*, Xiao-Qing Wang2,*, Kun Lu3,*, Xiao-Ling Deng3, Cheng-Wei Zhang4, Hong Luo2, Xu-Dong Xu2, Xiao-Man Chen2, Lu Yan5, Yi-Qing Wang2 and Song-Lin Shi3

1Medical College of Xiamen University, Jinshan Community Health Service Center, Xiamen Traditional Chinese Medical Hospital, Xiamen 361000, P.R. China

2Xiamen Heart Center, Medical College of Xiamen University, Xiamen 361000, P.R. China

3Department of Basic Medicine, Medical College of Xiamen University, Cancer Research Center of Xiamen University, Xiamen 361102, P.R. China

4Department of Cardiology, Affiliated Dongnan Hospital of Xiamen University, Zhangzhou 363000, P.R. China

5Department of Basic Medicine, Medical College of Xiamen University, Xiamen 361102, P.R. China

*These authors have contributed equally to this work

Correspondence to:

Yi-Qing Wang, email: [email protected]

Song-Lin Shi, email: [email protected]

Keywords: ephrin-B2, proliferation, migration, human umbilical vein endothelial cell, proteomic analysis

Received: December 09, 2016 Accepted: April 03, 2017 Published: April 20, 2017

ABSTRACT

Tumor growth and metastasis are angiogenesis dependent. Angiogenic growth involves endothelial cell proliferation, migration, and invasion. Ephrin-B2 is a ligand for Eph receptor tyrosine kinases and is an important mediator in vascular endothelial growth factor-mediated angiogenesis. However, research offer controversial information regarding effects of ephrin-B2 on vascular endothelial cells. In this paper, proteome analyses showed that ephrin-B2/Fc significantly activates multiple signaling pathways related to cell proliferation, survival, and migration and suppresses apoptosis and cell death. Cytological experiments further confirm that ephrin-B2/Fc stimulates endothelial cell proliferation, triggers dose-dependent migration, and suppresses cell apoptosis. Results demonstrate that soluble dose-dependent ephrinB2 can promote proliferation and migration and inhibit apoptosis of human umbilical vein endothelial cells. These results also suggest that ephrinB2 prevents ischemic disease and can potentially be a new therapeutic target for treating angiogenesis-related diseases and tumors.

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 17298

Publication Alerts

Research Papers:

Ephrin-B2/Fc promotes proliferation and migration, and suppresses apoptosis in human umbilical vein endothelial cells

Abstract